Sunesis Pharmaceuticals

Region Nordamerika
ISIN US8673288747
Sektor Biotechnologie
Website https://www.sunesis.com/

Sunesis is a clinical-stage biopharmaceutical company focused on the development and commercialization of new oncology therapeutics. With a passion to advance novel drugs, we are inspired to make a difference in cancer patients' lives.

Artikel über Sunesis Pharmaceuticals

Titel Autor Datum
Risikoarmes "Peak Play" mit Multibagger-Potenzial
sharedeals vor ungefähr 3 Monaten

News

Titel Datum
Sunesis Pharma to merge with Viracta Therapeutics in all-stock deal vor ungefähr 2 Monaten
SUNESIS PHARMACEUTICALS INC - 8-K, Current Report vor ungefähr 2 Monaten
Sunesis Pharmaceuticals, Inc.: Sunesis Pharmaceuticals and Viracta Therapeutics Announce Definitive Merger Agreement
SOUTH SAN FRANCISCO and SAN DIEGO, Calif., Nov. 30, 2020 (GLOBE NEWSWIRE) -- Sunesis Pharmaceutic...
vor ungefähr 2 Monaten
Sunesis Pharmaceuticals, Inc. (SNSS) Q3 2020 Results - Earnings Call Transcript vor ungefähr 2 Monaten
SUNESIS PHARMACEUTICALS INC - 10-Q, Quaterly Report vor ungefähr 2 Monaten